Abstract

The recent advancement in genome editing such a CRISPR/Cas9 system has enabled isolation of cells with knocked multiple alleles through a one-step transfection. Somatic cell nuclear transfer (SCNT) has been frequently employed as one of the efficient tools for the production of genetically modified (GM) animals. To use GM cells as SCNT donor, efficient isolation of transfectants with mutations at multiple target loci is often required. The methods for the isolation of such GM cells largely rely on the use of drug selection-based approach using selectable genes; however, it is often difficult to isolate cells with mutations at multiple target loci. In this study, we used a novel approach for the efficient isolation of porcine cells with at least two target loci mutations by one-step introduction of CRISPR/Cas9-related components. A single guide (sg) RNA targeted to GGTA1 gene, involved in the synthesis of cell-surface α-Gal epitope (known as xenogenic antigen), is always a prerequisite. When the transfected cells were reacted with toxin-labeled BS-I-B4 isolectin for 2 h at 37 °C to eliminate α-Gal epitope-expressing cells, the surviving clones lacked α-Gal epitope expression and were highly expected to exhibit induced mutations at another target loci. Analysis of these α-Gal epitope-negative surviving cells demonstrated a 100% occurrence of genome editing at target loci. SCNT using these cells as donors resulted in the production of cloned blastocysts with the genotype similar to that of the donor cells used. Thus, this novel system will be useful for SCNT-mediated acquisition of GM cloned piglets, in which multiple target loci may be mutated.

Highlights

  • The CRISPR/Cas9-mediated genome editing system is widely used to obtain cells exhibiting mutations at target loci, after a one-step introduction of DNA or mRNA [1,2]

  • We first attempted to examine whether the endogenous low-density lipoprotein receptor (LDLR) gene undergoes efficient genome editing in cultured porcine cells using our system

  • Performing a polymerase chain reaction (PCR) for the amplification of a region spanning the mutated target gene, using the genomic DNA isolated from these clones, resulted in the successful production of 355- and 351-bp bands of expected size for the LDLR and GGTA1 genes, respectively (Figure 2C)

Read more

Summary

Introduction

The CRISPR/Cas9-mediated genome editing system is widely used to obtain cells exhibiting mutations at target loci, after a one-step introduction of DNA or mRNA [1,2] It involves the co-transfection of a single guide (sg) RNA and Cas expression vectors, which include either an antibiotic resistance marker (i.e., puromycin resistance gene) or a fluorescent protein reporter (i.e., green fluorescent protein [GFP]) [3,4,5,6,7,8,9,10]. Drug-free enrichment of the genome-edited cells, through the simple cultivation of cells after transfection with CRISPR/Cas9-related components may be a desirable way to perform cell selection

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call